
Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Globa
Description
Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Global Forecast 2024-2030
The Metagenomic Sequencing Market size was estimated at USD 2.15 billion in 2023 and expected to reach USD 2.39 billion in 2024, at a CAGR 12.43% to reach USD 4.89 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Metagenomic Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Metagenomic Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Metagenomic Sequencing Market, highlighting leading vendors and their innovative profiles. These include Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.
Market Segmentation & Coverage
This research report categorizes the Metagenomic Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product & Service
Analysis & Data Interpretation Solutions
Instruments
Reagents & Consumables
Services
Workflow
Data Processing & Analysis
Sample Processing & Library Preparation
Sequencing
Technology
16S rRNA Sequencing
Metatranscriptomics
Shotgun Metagenomic Sequencing
Whole-genome Sequencing & De Novo Assembly
Application
Clinical Diagnostics
Drug Discovery
Ecological & Environmental Applications
Industrial applications
Soil Microbiome Applications
Veterinary Applications
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Metagenomic Sequencing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Metagenomic Sequencing Market?
3. What are the technology trends and regulatory frameworks in the Metagenomic Sequencing Market?
4. What is the market share of the leading vendors in the Metagenomic Sequencing Market?
5. Which modes and strategic moves are suitable for entering the Metagenomic Sequencing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Metagenomic Sequencing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising need for the evaluation of bacterial diversity and detection of various microbes
- 5.1.1.2. Growing prevalence of genetic disorders worldwide
- 5.1.1.3. Rising investment by government and private sector for sequencing projects
- 5.1.2. Restraints
- 5.1.2.1. Limited storage for the sequencing data
- 5.1.2.2. High price for the end-user in developing countries
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancement for the metagenomic sequencing data management
- 5.1.3.2. Technological development for better metagenomic sequencing
- 5.1.4. Challenges
- 5.1.4.1. Dearth of skilled and experienced workforce
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Metagenomic Sequencing Market, by Product & Service
- 6.1. Introduction
- 6.2. Analysis & Data Interpretation Solutions
- 6.3. Instruments
- 6.4. Reagents & Consumables
- 6.5. Services
- 7. Metagenomic Sequencing Market, by Workflow
- 7.1. Introduction
- 7.2. Data Processing & Analysis
- 7.3. Sample Processing & Library Preparation
- 7.4. Sequencing
- 8. Metagenomic Sequencing Market, by Technology
- 8.1. Introduction
- 8.2. 16S rRNA Sequencing
- 8.3. Metatranscriptomics
- 8.4. Shotgun Metagenomic Sequencing
- 8.5. Whole-genome Sequencing & De Novo Assembly
- 9. Metagenomic Sequencing Market, by Application
- 9.1. Introduction
- 9.2. Clinical Diagnostics
- 9.3. Drug Discovery
- 9.4. Ecological & Environmental Applications
- 9.5. Industrial applications
- 9.6. Soil Microbiome Applications
- 9.7. Veterinary Applications
- 10. Americas Metagenomic Sequencing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Metagenomic Sequencing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Metagenomic Sequencing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Azenta US, Inc.
- 14.1.2. BGI Genomics Co., Ltd.
- 14.1.3. CosmosID
- 14.1.4. DNASTAR, Inc.
- 14.1.5. Eurofins Genomics Germany GmbH
- 14.1.6. Freenome Holdings, Inc.
- 14.1.7. IntegraGen S.A.
- 14.1.8. Macrogen Europe BV
- 14.1.9. Microsynth AG
- 14.1.10. Novogene Co., Ltd.
- 14.1.11. Oxford Nanopore Technologies PLC
- 14.1.12. Pacific Biosciences of California, Inc.
- 14.1.13. PerkinElmer Inc.
- 14.1.14. Psomagen, Inc.
- 14.1.15. QIAGEN GmbH
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. METAGENOMIC SEQUENCING MARKET RESEARCH PROCESS
- FIGURE 2. METAGENOMIC SEQUENCING MARKET SIZE, 2023 VS 2030
- FIGURE 3. METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. METAGENOMIC SEQUENCING MARKET DYNAMICS
- FIGURE 7. METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
- FIGURE 8. METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
- FIGURE 10. METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 12. METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.